Oxford/AstraZeneca vaccine results face growing scrutinyNovember 26, 2020
Share price drops as critics question claim vaccine could protect up to 90% of people
- What tier am I in? Latest Covid rules in England post-lockdown
- Coronavirus – latest updates
- See all our coronavirus coverage
The Oxford University/AstraZeneca vaccine is coming under increasing scrutiny, with critics questioning the claim that trials showed it could protect up to 90% of people against coronavirus.
On Thursday Sir John Bell, Oxford’s regius professor of medicine and the UK government’s life sciences adviser, dismissed suggestions the trial had not been properly set up or reported. “We weren’t cooking this up as we went along,” he said, adding that he hoped the full, peer-reviewed data would be published in the Lancet medical journal at the weekend.